trastuzumab,neratinib
roche,knight therapeutics,pierre fabre,puma
['summit', 'neratinib', 'puma', 'pbyi', 'biotec']
just in: $pbyi puma biotechnology presents final results from the biliary tract cohort of the phase 2 summit 'basket' trial of neratinib at the asco 2022 annual meeting #mwn #stocks $pbyi $wti $rxrx
Market Wire News is a news platform to help research, connect and engage